Trenton, NJ (July 9, 2018) – BioNJ, the trade association for New Jersey’s life sciences industry, announced that John Slotman joined the organization as Vice President, Government Affairs. John has nearly 20 years of experience in the healthcare and public policy sectors with broad strategic and tactical experience in government relations, policy and advocacy.
John recently served as Vice President, Graduate Medical Education Policy and Teaching Hospital Issues, for the New Jersey Hospital Association where he focused on issues related to New Jersey’s 43 teaching hospitals. Prior to joining the New Jersey Hospital Association in 2013, John served as Policy Advisor for DLA Piper where he represented clients to Congressional Republicans and Democrats, including House and Senate leadership, relevant committees and regulatory agencies on issues of interest to healthcare providers, pharmaceutical manufacturers, insurers and others. John’s vast experience includes government affairs positions at the Generic Pharmaceutical Association and the American Hospital Association; as well as working on the legislative teams for Congresswoman Jo Ann Emerson and Congressman Bill Shuster.
“Given the political climate in Trenton and on the Hill, we are thrilled to have someone with John’s experience and talents to lead BioNJ’s advocacy efforts at the State and federal levels as BioNJ champions policy initiatives to help our Members help Patients,” said BioNJ President and CEO Debbie Hart.
John can be reached at JSlotman@BioNJ.org or at 609-890-3185.
BioNJ is a trade association of nearly 400 Member companies representing research-based life sciences organizations and stakeholders dedicated to propelling a vibrant ecosystem where Science is Supported, Companies are Created, Drugs are Developed and Patients are Paramount. Because Patients Can’t Wait®, BioNJ supports its Members in the discovery, development and commercialization of therapies and cures that save and improve lives and lessen the burden of illness and disease to society by driving capital formation, fostering entrepreneurship, advocating for public policies that advance medical innovation, providing access to talent and education and offering a cost-saving array of critical commercial resources. For more information about BioNJ, please visit www.BioNJ.org.
Vice President, Communications and Marketing